US Stock MarketDetailed Quotes

CMND Clearmind Medicine

Watchlist
  • 1.0700
  • +0.0200+1.90%
Close Mar 28 16:00 ET
  • 1.0700
  • 0.00000.00%
Post 20:01 ET
5.49MMarket Cap-1.04P/E (TTM)

Clearmind Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jan 31, 2025
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
(Q1)Jan 31, 2024
(FY)Oct 31, 2023
(Q4)Oct 31, 2023
(Q3)Jul 31, 2023
(Q2)Apr 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
13.44%-1.27M
22.90%-4.86M
-43.02%-1.08M
18.09%-1.13M
-11.55%-1.19M
52.89%-1.46M
-69.19%-6.3M
-265.81%-753.17K
-424.00%-1.38M
42.38%-1.07M
Net income from continuing operations
21.65%-1.07M
39.05%-5.25M
78.26%-884.74K
-264.04%-2.09M
56.26%-908.22K
27.99%-1.37M
-25.03%-8.62M
-160.00%-4.07M
60.92%-575.19K
6.44%-2.08M
Operating gains losses
-1,125.20%-510.5K
-121.44%-586.71K
-142.34%-1.21M
235.54%654.49K
-96.89%11.03K
-843.92%-41.67K
841.80%2.74M
--2.86M
---482.88K
--354.88K
Depreciation and amortization
39.47%12.04K
-11.19%51.07K
186.58%11.51K
-15.21%15.19K
15.87%15.74K
-60.76%8.63K
-30.77%57.51K
-84.71%4.02K
-59.35%17.92K
324.05%13.58K
Deferred tax
-80.48%39.34K
497.97%103.88K
464.78%64.12K
-374.71%-31.48K
-1,505.67%-130.26K
5,856.25%201.5K
-41.82%17.37K
-61.98%11.35K
---6.63K
--9.27K
Other non cash items
127,700.00%1.28K
85.28%5.39K
--1.46K
920.00%2.3K
461.38%1.63K
-99.96%1
-79.86%2.91K
--0
--225
--290
Change In working capital
36.37%-188.4K
86.57%-130.11K
-28.77%274.11K
88.51%-50.6K
-109.59%-57.51K
80.43%-296.11K
-178.36%-969.03K
-50.39%384.82K
-178.19%-440.47K
1,266.98%599.6K
-Change in receivables
-129.09%-27.22K
142.01%64.95K
1,045.75%10.13K
67.65%-17.26K
-122.67%-21.49K
147.98%93.57K
-875.51%-154.62K
98.30%-1.07K
-136.63%-53.35K
202.58%94.83K
-Change in prepaid assets
11.44%-244.88K
85.88%-3.69K
-27.86%79.69K
-22.58%87.04K
-75.68%106.08K
59.65%-276.5K
-125.37%-26.13K
8,598.03%110.47K
681.68%112.43K
1,039.25%436.23K
-Change in payables and accrued expense
138.12%84.76K
67.99%-198.59K
-34.02%183.69K
62.05%-127K
-8.51%-32.92K
58.35%-222.36K
-167.93%-620.42K
-56.29%278.37K
-182.98%-334.64K
-1,194.20%-30.34K
-Change in other working capital
-100.98%-1.07K
104.30%7.22K
120.66%610
----
----
210.42%109.18K
-183.74%-167.86K
---2.95K
----
----
Cash from discontinued investing activities
Operating cash flow
13.44%-1.27M
22.90%-4.86M
-43.02%-1.08M
18.09%-1.13M
-11.55%-1.19M
52.89%-1.46M
-69.19%-6.3M
-265.81%-753.17K
-424.00%-1.38M
42.38%-1.07M
Investing cash flow
Cash flow from continuing investing activities
69.46K
-807.80%-238.1K
-933.20%-350.4K
339.80%33.8K
78.5K
0
-371.47%-26.23K
-509.64%-33.91K
7.69K
Net PPE purchase and sale
----
--0
----
----
----
----
--0
----
----
----
Net investment purchase and sale
--82.96K
---271.9K
---350.4K
--0
--78.5K
--0
--0
--0
--0
----
Net other investing changes
---13.5K
228.88%33.8K
--0
----
----
----
---26.23K
---33.91K
----
----
Cash from discontinued investing activities
Investing cash flow
--69.46K
-807.80%-238.1K
-933.20%-350.4K
339.80%33.8K
--78.5K
--0
-371.47%-26.23K
-509.64%-33.91K
--7.69K
----
Financing cash flow
Cash flow from continuing financing activities
-92.39%404.81K
-46.38%6.25M
-86.56%323.21K
1,581.84%469.54K
-95.07%145.13K
-16.25%5.32M
2,179.59%11.66M
10,750.80%2.41M
66.55%-31.69K
367.83%2.94M
Net issuance payments of debt
-63.13%-10.27K
-4.07%-42.59K
---10.03K
-35.52%-13.47K
15.88%-12.79K
60.09%-6.3K
42.26%-40.92K
--0
79.42%-9.94K
---15.2K
Net common stock issuance
--0
-80.28%2.19M
-85.44%264.28K
575.39%103.39K
--0
-71.33%1.82M
1,808.01%11.12M
181,519,200.00%1.82M
53.18%-21.75K
370.25%2.96M
Proceeds from stock option exercised by employees
-88.13%415.09K
595.59%4.1M
-88.31%68.95K
--379.62K
--157.92K
--3.5M
--590.08K
--590.08K
--0
--0
Cash from discontinued financing activities
Financing cash flow
-92.39%404.81K
-46.38%6.25M
-86.56%323.21K
1,581.84%469.54K
-95.07%145.13K
-16.25%5.32M
2,179.59%11.66M
3,584.23%2.41M
34.38%-31.69K
367.83%2.94M
Net cash flow
Beginning cash position
21.12%6.57M
4,114.84%5.43M
99.61%7.68M
58.34%8.31M
175.60%9.29M
4,114.84%5.43M
-96.18%128.78K
897.17%3.85M
606.07%5.25M
52.89%3.37M
Current changes in cash
-120.53%-791.16K
-78.31%1.16M
-168.25%-1.1M
55.46%-623.4K
-151.73%-969.15K
18.79%3.85M
265.82%5.34M
791.43%1.62M
-291.77%-1.4M
252.70%1.87M
Effect of exchange rate changes
-139.11%-1.46K
69.40%-11.55K
96.04%-1.5K
-338.44%-2.88K
-464.36%-10.9K
188.14%3.72K
-66.58%-37.73K
-63.90%-37.71K
750.00%1.21K
464.78%2.99K
End cash Position
-37.74%5.78M
21.12%6.57M
21.12%6.57M
99.61%7.68M
58.34%8.31M
175.60%9.29M
4,114.84%5.43M
4,114.84%5.43M
897.17%3.85M
606.07%5.25M
Free cash flow
13.44%-1.27M
22.90%-4.86M
-43.02%-1.08M
18.09%-1.13M
-11.55%-1.19M
52.89%-1.46M
-68.94%-6.3M
-256.19%-753.17K
-424.00%-1.38M
42.38%-1.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Jan 31, 2025(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q3)Jul 31, 2024(Q2)Apr 30, 2024(Q1)Jan 31, 2024(FY)Oct 31, 2023(Q4)Oct 31, 2023(Q3)Jul 31, 2023(Q2)Apr 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 13.44%-1.27M22.90%-4.86M-43.02%-1.08M18.09%-1.13M-11.55%-1.19M52.89%-1.46M-69.19%-6.3M-265.81%-753.17K-424.00%-1.38M42.38%-1.07M
Net income from continuing operations 21.65%-1.07M39.05%-5.25M78.26%-884.74K-264.04%-2.09M56.26%-908.22K27.99%-1.37M-25.03%-8.62M-160.00%-4.07M60.92%-575.19K6.44%-2.08M
Operating gains losses -1,125.20%-510.5K-121.44%-586.71K-142.34%-1.21M235.54%654.49K-96.89%11.03K-843.92%-41.67K841.80%2.74M--2.86M---482.88K--354.88K
Depreciation and amortization 39.47%12.04K-11.19%51.07K186.58%11.51K-15.21%15.19K15.87%15.74K-60.76%8.63K-30.77%57.51K-84.71%4.02K-59.35%17.92K324.05%13.58K
Deferred tax -80.48%39.34K497.97%103.88K464.78%64.12K-374.71%-31.48K-1,505.67%-130.26K5,856.25%201.5K-41.82%17.37K-61.98%11.35K---6.63K--9.27K
Other non cash items 127,700.00%1.28K85.28%5.39K--1.46K920.00%2.3K461.38%1.63K-99.96%1-79.86%2.91K--0--225--290
Change In working capital 36.37%-188.4K86.57%-130.11K-28.77%274.11K88.51%-50.6K-109.59%-57.51K80.43%-296.11K-178.36%-969.03K-50.39%384.82K-178.19%-440.47K1,266.98%599.6K
-Change in receivables -129.09%-27.22K142.01%64.95K1,045.75%10.13K67.65%-17.26K-122.67%-21.49K147.98%93.57K-875.51%-154.62K98.30%-1.07K-136.63%-53.35K202.58%94.83K
-Change in prepaid assets 11.44%-244.88K85.88%-3.69K-27.86%79.69K-22.58%87.04K-75.68%106.08K59.65%-276.5K-125.37%-26.13K8,598.03%110.47K681.68%112.43K1,039.25%436.23K
-Change in payables and accrued expense 138.12%84.76K67.99%-198.59K-34.02%183.69K62.05%-127K-8.51%-32.92K58.35%-222.36K-167.93%-620.42K-56.29%278.37K-182.98%-334.64K-1,194.20%-30.34K
-Change in other working capital -100.98%-1.07K104.30%7.22K120.66%610--------210.42%109.18K-183.74%-167.86K---2.95K--------
Cash from discontinued investing activities
Operating cash flow 13.44%-1.27M22.90%-4.86M-43.02%-1.08M18.09%-1.13M-11.55%-1.19M52.89%-1.46M-69.19%-6.3M-265.81%-753.17K-424.00%-1.38M42.38%-1.07M
Investing cash flow
Cash flow from continuing investing activities 69.46K-807.80%-238.1K-933.20%-350.4K339.80%33.8K78.5K0-371.47%-26.23K-509.64%-33.91K7.69K
Net PPE purchase and sale ------0------------------0------------
Net investment purchase and sale --82.96K---271.9K---350.4K--0--78.5K--0--0--0--0----
Net other investing changes ---13.5K228.88%33.8K--0---------------26.23K---33.91K--------
Cash from discontinued investing activities
Investing cash flow --69.46K-807.80%-238.1K-933.20%-350.4K339.80%33.8K--78.5K--0-371.47%-26.23K-509.64%-33.91K--7.69K----
Financing cash flow
Cash flow from continuing financing activities -92.39%404.81K-46.38%6.25M-86.56%323.21K1,581.84%469.54K-95.07%145.13K-16.25%5.32M2,179.59%11.66M10,750.80%2.41M66.55%-31.69K367.83%2.94M
Net issuance payments of debt -63.13%-10.27K-4.07%-42.59K---10.03K-35.52%-13.47K15.88%-12.79K60.09%-6.3K42.26%-40.92K--079.42%-9.94K---15.2K
Net common stock issuance --0-80.28%2.19M-85.44%264.28K575.39%103.39K--0-71.33%1.82M1,808.01%11.12M181,519,200.00%1.82M53.18%-21.75K370.25%2.96M
Proceeds from stock option exercised by employees -88.13%415.09K595.59%4.1M-88.31%68.95K--379.62K--157.92K--3.5M--590.08K--590.08K--0--0
Cash from discontinued financing activities
Financing cash flow -92.39%404.81K-46.38%6.25M-86.56%323.21K1,581.84%469.54K-95.07%145.13K-16.25%5.32M2,179.59%11.66M3,584.23%2.41M34.38%-31.69K367.83%2.94M
Net cash flow
Beginning cash position 21.12%6.57M4,114.84%5.43M99.61%7.68M58.34%8.31M175.60%9.29M4,114.84%5.43M-96.18%128.78K897.17%3.85M606.07%5.25M52.89%3.37M
Current changes in cash -120.53%-791.16K-78.31%1.16M-168.25%-1.1M55.46%-623.4K-151.73%-969.15K18.79%3.85M265.82%5.34M791.43%1.62M-291.77%-1.4M252.70%1.87M
Effect of exchange rate changes -139.11%-1.46K69.40%-11.55K96.04%-1.5K-338.44%-2.88K-464.36%-10.9K188.14%3.72K-66.58%-37.73K-63.90%-37.71K750.00%1.21K464.78%2.99K
End cash Position -37.74%5.78M21.12%6.57M21.12%6.57M99.61%7.68M58.34%8.31M175.60%9.29M4,114.84%5.43M4,114.84%5.43M897.17%3.85M606.07%5.25M
Free cash flow 13.44%-1.27M22.90%-4.86M-43.02%-1.08M18.09%-1.13M-11.55%-1.19M52.89%-1.46M-68.94%-6.3M-256.19%-753.17K-424.00%-1.38M42.38%-1.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Cisco
CSCO
-0.88%
NVIDIA
NVDA
-1.58%
Broadcom
AVGO
-1.67%
Taiwan Semiconductor
TSM
-1.78%
ASML Holding
ASML
-2.32%

Unlock the Full List